153 related articles for article (PubMed ID: 38194774)
21. A tangible method to assess native ferroptosis suppressor activity.
Nakamura T; Ito J; Mourão ASD; Wahida A; Nakagawa K; Mishima E; Conrad M
Cell Rep Methods; 2024 Mar; 4(3):100710. PubMed ID: 38401540
[TBL] [Abstract][Full Text] [Related]
22. Intracellular Delivery of Glutathione Peroxidase Degrader Induces Ferroptosis In Vivo.
Luo T; Zheng Q; Shao L; Ma T; Mao L; Wang M
Angew Chem Int Ed Engl; 2022 Sep; 61(39):e202206277. PubMed ID: 35924720
[TBL] [Abstract][Full Text] [Related]
23. Discovery and optimization of indirubin derivatives as novel ferroptosis inducers for the treatment of colon cancer.
Zhu JM; Chen C; Kong M; Zhu L; Li YL; Zhang JF; Yu ZP; Xu SS; Kong LY; Luo JG
Eur J Med Chem; 2023 Dec; 261():115829. PubMed ID: 37801824
[TBL] [Abstract][Full Text] [Related]
24. Novel Covalent Probe Selectively Targeting Glutathione Peroxidase 4 In Vivo: Potential Applications in Pancreatic Cancer Therapy.
Tang Z; Li J; Peng L; Xu F; Tan Y; He X; Zhu C; Zhang ZM; Zhang Z; Sun P; Ding K; Li Z
J Med Chem; 2024 Feb; 67(3):1872-1887. PubMed ID: 38265413
[TBL] [Abstract][Full Text] [Related]
25. Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer.
Sekhar KR; Hanna DN; Cyr S; Baechle JJ; Kuravi S; Balusu R; Rathmell K; Baregamian N
Sci Rep; 2022 Nov; 12(1):19396. PubMed ID: 36371529
[TBL] [Abstract][Full Text] [Related]
26. Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy.
Kahn-Kirby AH; Amagata A; Maeder CI; Mei JJ; Sideris S; Kosaka Y; Hinman A; Malone SA; Bruegger JJ; Wang L; Kim V; Shrader WD; Hoff KG; Latham JC; Ashley EA; Wheeler MT; Bertini E; Carrozzo R; Martinelli D; Dionisi-Vici C; Chapman KA; Enns GM; Gahl W; Wolfe L; Saneto RP; Johnson SC; Trimmer JK; Klein MB; Holst CR
PLoS One; 2019; 14(3):e0214250. PubMed ID: 30921410
[TBL] [Abstract][Full Text] [Related]
27. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
[TBL] [Abstract][Full Text] [Related]
28. Cyclophosphamide-induced GPX4 degradation triggers parthanatos by activating AIFM1.
Liu L; Liu B; Guan G; Kang R; Dai Y; Tang D
Biochem Biophys Res Commun; 2022 May; 606():68-74. PubMed ID: 35339754
[TBL] [Abstract][Full Text] [Related]
29. The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1.
Cheff DM; Huang C; Scholzen KC; Gencheva R; Ronzetti MH; Cheng Q; Hall MD; Arnér ESJ
Redox Biol; 2023 Jun; 62():102703. PubMed ID: 37087975
[TBL] [Abstract][Full Text] [Related]
30. NMN recruits GSH to enhance GPX4-mediated ferroptosis defense in UV irradiation induced skin injury.
Feng Z; Qin Y; Huo F; Jian Z; Li X; Geng J; Li Y; Wu J
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166287. PubMed ID: 34626772
[TBL] [Abstract][Full Text] [Related]
31. Acid-Responsive Micelles Releasing Cinnamaldehyde Enhance RSL3-Induced Ferroptosis in Tumor Cells.
Yan Z; Wu S; Zhou Y; Li F
ACS Biomater Sci Eng; 2022 Jun; 8(6):2508-2517. PubMed ID: 35648631
[TBL] [Abstract][Full Text] [Related]
32. Discovery of a Potent Chloroacetamide GPX4 Inhibitor with Bioavailability to Enable Target Engagement in Mice, a Potential Tool Compound for Inducing Ferroptosis
Randolph JT; O'Connor MJ; Han F; Hutchins CW; Siu YA; Cho M; Zheng Y; Hickson JA; Markley JL; Manaves V; Algire M; Baker KA; Chapman AM; Gopalakrishnan SM; Panchal SC; Foster-Duke K; Stolarik DF; Kempf-Grote A; Dammeier D; Fossey S; Sun Q; Sun C; Shen Y; Dart MJ; Kati WM; Lai A; Firestone AJ; Kort ME
J Med Chem; 2023 Mar; 66(6):3852-3865. PubMed ID: 36877935
[TBL] [Abstract][Full Text] [Related]
33. Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience.
Lee J; Roh JL
Cancer Lett; 2023 Apr; 559():216119. PubMed ID: 36893895
[TBL] [Abstract][Full Text] [Related]
34. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system.
Jin M; Shi C; Li T; Wu Y; Hu C; Huang G
Biomed Pharmacother; 2020 Sep; 129():110282. PubMed ID: 32531676
[TBL] [Abstract][Full Text] [Related]
35. Ketamine suppresses proliferation and induces ferroptosis and apoptosis of breast cancer cells by targeting KAT5/GPX4 axis.
Li H; Liu W; Zhang X; Wu F; Sun D; Wang Z
Biochem Biophys Res Commun; 2021 Dec; 585():111-116. PubMed ID: 34800882
[TBL] [Abstract][Full Text] [Related]
36. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer.
Mao C; Liu X; Zhang Y; Lei G; Yan Y; Lee H; Koppula P; Wu S; Zhuang L; Fang B; Poyurovsky MV; Olszewski K; Gan B
Nature; 2021 May; 593(7860):586-590. PubMed ID: 33981038
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis.
Jelinek A; Heyder L; Daude M; Plessner M; Krippner S; Grosse R; Diederich WE; Culmsee C
Free Radic Biol Med; 2018 Mar; 117():45-57. PubMed ID: 29378335
[TBL] [Abstract][Full Text] [Related]
38. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
39. Bufotalin induces ferroptosis in non-small cell lung cancer cells by facilitating the ubiquitination and degradation of GPX4.
Zhang W; Jiang B; Liu Y; Xu L; Wan M
Free Radic Biol Med; 2022 Feb; 180():75-84. PubMed ID: 35038550
[TBL] [Abstract][Full Text] [Related]
40. Boosting the Ferroptotic Antitumor Efficacy via Site-Specific Amplification of Tailored Lipid Peroxidation.
An Y; Zhu J; Liu F; Deng J; Meng X; Liu G; Wu H; Fan A; Wang Z; Zhao Y
ACS Appl Mater Interfaces; 2019 Aug; 11(33):29655-29666. PubMed ID: 31359759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
